TSM-associated metabolomic signature
1 paper2 findings
- Humans1
Effects
1SCORE2
upin humans1
1 study
SCORE2
upin humans1
TSM-associated metabolomic signature improves SCORE2 in humans (AUC 0.584 to 0.660).
“Adding TSM or the metabolomic signature to SCORE2 improved 10‐year risk discrimination (area under the curve 0.584 to 0.657 and 0.660, respectively)”
Humansfemalesn = 67,582
npj aging6 Jan 2026
Associations
1Cardiovascular disease
upin humans1HR 1.18
1 study
Cardiovascular disease
upin humans1HR 1.18
TSM-associated metabolomic signature raises the risk of cardiovascular disease in humans (HR 1.18, 95% CI 1.15-1.21 per 1-SD increase).
“each 1-standard deviation increases in the metabolomic signature (HR 1.18, 95% CI 1.15-1.21) were independently associated with higher composite CVD risk”
Humansfemalesn = 67,582
npj aging6 Jan 2026
Latest
1 in 12 monthsnpj Aging
Integrating menopause duration and plasma metabolomics enhances cardiovascular risk stratification in aging women
Cohort study of 67,582 peopleCardiovascular disease